InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: None

Tuesday, 04/21/2015 8:13:03 AM

Tuesday, April 21, 2015 8:13:03 AM

Post# of 8545


Sunday, May 31 | 8:00 AM - 11:00 AM


Gastrointestinal (Noncolorectal) Cancer

Session Type: Oral Abstract Session
Track(s): Gastrointestinal (Noncolorectal) Cancer
Presentation(s):



Abstract #4006

10:00 AM - 10:12 AM

High response rate and PFS with PEGPH20 added to nab-paclitaxel/gemcitabine in stage IV previously untreated pancreatic cancer patients with high-HA tumors: Interim results of a randomized phase II study.

Sunil R. Hingorani, MD, PhD

Fred Hutchinson Cancer Research Center

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News